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Abstract
Purpose The purpose of this study is to characterize health status of older cancer survivors using data from the population-based
PolSenior study.
Methods We compared cancer survivors and non-cancer subjects according to comorbidities, functional status, mental health,
and sociodemographic factors.
Results There were 286 (5.8%) cancer survivors in a population of 4943 adults aged 65 years and older. The mean age of cancer
survivors was 79.4 ± 8.2 years and the median time since cancer diagnosis was 8.5 years (Q1–Q3: 4–16 years). After adjustment
for age, sex, education, marital status, and number of comorbidities, compared with a non-cancer population, cancer survivors
were more likely to experience falls (OR = 1.38; 95% CI: 1.04–1.83), and to report poor health (OR = 1.49; 95%CI: 1.83–2.06),
but cancer survivorship was not associated with impairments in instrumental activities of daily living (IADLs). Age and
university education, but neither the time from cancer diagnosis nor the number of comorbidities, were associated with impair-
ments in cancer survivors. Three or more chronic diseases were found in over 50% of cancer survivors and in 38% of the non-
cancer population (p < 0.001).
Conclusions Cancer survivors over the age of 65 years have a higher prevalence of falls, are more likely to report poor health
status, and have a higher number of chronic conditions than the non-cancer population, but they maintain independence in
IADLs. Advanced age and elementary education are associated with increased occurrence of functional impairments in older
cancer survivors
Implications for cancer survivors Older cancer survivors may require preventive services to reduce the risk of functional decline.
Keywords Cancer survivor . Elderly . Comorbidity . Health status . Falls
Introduction
The prevalence of malignancy increases with aging, and
around 60% of people diagnosed with cancer are over 65 years
old. Cancer incidence rates in older adults in Poland in 2006
were 1818.5 per 100,000 in men and 923.1 per 100,000 in
women, and cancer was diagnosed almost 2.5 times more
often in adults over 65 years of age compared to individuals
aged 45–64 years old [1]. Improved cancer diagnosis and care
results in increasing numbers of survivors: There were over 32
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million 5-year cancer survivors worldwide in 2012 (http://
www.cdc.gov/cancer/international/statistics.html). The
prevalence of cancer survivors in Europe is estimated to be
2% on average and 1% in Poland [2].
The toxicity of anticancer therapies in older individuals is
added to age-associated alterations and an age-related increase
in the prevalence of chronic diseases. Therefore, it has been
recognized that older cancer survivors have a higher number
of comorbidities: They are more likely to have one or more
chronic conditions (42.1 vs 19.7%), and the age-adjusted
prevalence of cardiovascular diseases is significantly higher
in cancer survivors than in patients without a history of cancer
(24.5 vs 22.9%). Patients who present with both cancer and
concomitant diseases have an almost sixfold higher risk of
psychological disorders (depression, anxiety, and adjustment
disorders) than individuals without a history of cancer [3, 4].
The aim of this study was to characterize elderly cancer
survivors (patients diagnosed with cancer, either currently un-
dergoing treatment or currently free of cancer) in a represen-
tative Polish population-based sample of people aged 65 years
and older, and to compare the occurrence of comorbidities,
functional and cognitive abilities, and sociodemographic char-
acteristics in relation to non-cancer subjects.
Material and methods
Study population
PolSenior is a population-based study conducted over the
years 2007–2011 with a representative sample of the Polish
population aged 65 years and older. The participants were
recruited from all administrative regions in Poland using a
three-stage stratified, proportional draw, with a response rate
of 43%. The study was based on a standardized questionnaire,
comprehensive geriatric assessment, and blood and urine sam-
pling. The survey included data on socio-economic, function-
al, and cognitive status and concomitant diseases. The details
of the design and recruitment criteria for the PolSenior survey,
as well as descriptions of examination procedures and the
structure of the study group have been reported previously [5].
Social characteristics
The measures included current marital status (classified in the
present analyses as married or not married) and cohabitation
status (living alone, cohabiting, and institutional), receiving
any social benefits (yes/no), declared need for assistance in
performing daily activities (yes/no), educational level (ele-
mentary, high school, and university), and living area (rural,
urban with a population of at least 50,000, urban with a pop-
ulation of more than 50,000).
Self-reported health status
All participants were asked to assess their present general
health using the 10-point visual analogue scale (VAS); in the
analyses, a score of 0–4 was classified as Bpoor health.^
Cancer history
All participants were asked about their history of cancer, can-
cer type, age at diagnosis, and the status of cancer treatment
(cured = treatment completed at least 5 years prior to the
study; last treatment within 5 years prior to the study; currently
undergoing clinical treatment). In the analyses, we use the
term Bcancer survivors^ to define patients diagnosed with
cancer undergoing treatment or cancer-free [2] (https://
cancercontrol.cancer.gov/ocs/statistics/definitions.html).
Answering Byes^ to the question BHave you ever been
diagnosed with cancer?^ defined a person as a cancer
survivor. In this article, the terms Bcancer survivors^ and
Bpatients with self-reported cancer history^ are used
interchangeably.
Chronic conditions
The study considered cardiovascular diseases (including hy-
pertension, coronary heart disease, myocardial infarction, and
stroke), respiratory, digestive, endocrine, and metabolic dis-
eases (including diabetes mellitus), blood diseases (anemia),
kidney diseases, osteoporosis, and eye diseases.
Geriatric assessment
This included the occurrence of falls within 12months prior to
the study, the ability to perform instrumental activities of daily
living (IADLs) measured using the Lawton IADL scale (no
deficits in IADL defined as a score of 24/24), screening for
depression using the short version of the Geriatric Depression
Scale (GDS) (depression defined as a score ≥ 6/15), and cog-
nitive impairment assessed using screening test: the Mini-
Mental State Examination (MMSE) (< 24/30 points indicating
impaired cognitive performance).
Statistical analyses
To describe the data collected, mean values (for age) and me-
dian values for the first (Q1) and third (Q3) quartiles of the
duration of disease were used. The cancer survivor group was
compared with the group of respondents with no self-reported
cancer history (non-cancer population) using the chi-squared
test of independence, and the frequency of given conditions
was presented. The relationship between self-reported cancer
status and the presence of some limitations in functional
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activity, depression, dementia, need for support in everyday
life, and falls, as well as poor self-rated health, was analyzed
using multivariate logistic regression models. The set of pos-
sible covariates, including age (5-year groups, reference age
65–69), sex (ref. male), marital status (ref. not married), uni-
versity education (ref. elementary education), and number of
chronic diseases reported (none, 1, 2, or 3+), was used in all
models. The results were presented as odds ratios (ORs) and
95% confidence intervals (95% CI). The next step of the anal-
ysis was to assess if there was any relation between the time
from cancer diagnosis and the studied outcomes among respon-
dents with a self-reported cancer history using multivariate lo-
gistic regression with the following covariates: age, sex, educa-
tion, marital status, and number of comorbidities. For the pur-
pose of this analysis, as a consequence of a number of missing
data concerning the time of diagnosis and present status of the
disease, analyses were performed with a smaller sample size.
All analyses were performed in STATA 13 (StataCorp LLC,
Texas, USA), and the statistical significance for all tests was
0.05.
Results
Characteristics of cancer survivors
There were 286 cancer survivors (5.8%) in a population of
4943 adults aged 65 years and older. The mean age of cancer
survivors was 79.4 ± 8.2 years. In all, 72% of cancer survivors
were 75 years and older and 44.8% were women. Nearly 60%
of cancer survivors declared being cured of cancer; the other
participants were either currently undergoing clinical treat-
ment or had completed treatment less than 5 years prior to
the study. The median time since cancer diagnosis was
8.5 years (Q1–Q3: 4–16) and median age at cancer diagnosis
was 68 years (Q1–Q3: 60–76). Nearly two out of three cancer
survivors (65.4%) were diagnosed with cancer over the age of
65 years, and 39.3% of cancer survivors were diagnosed with
cancer 10 or more years prior to the study.
The level of education in cancer survivors was higher than
in the non-cancer population, and they were more often urban
dwellers, while marital and cohabitation status was compara-
ble in both groups. Cancer survivors more often declared the
use of social services in comparison to the non-cancer popu-
lation. The characteristics of respondents with and without a
history of cancer are presented in Table 1.
The most prevalent types of cancer among survivors were
colorectal (16.6%), prostate (14.2%), and breast (13.9%) com-
prising about 45% of the reported cancers. In terms of
coexisting diseases, three or more chronic diseases were found
in over 50% of cancer survivors and in 38% of the non-cancer
population (Fig. 1). The mean number of concomitant dis-
eases in cancer survivors was higher than in the non-cancer
population (3.8 and 2.3, respectively). Cancer survivors more
frequently reported having cardiovascular disorders (75 vs.
69%, p = 0.037), endocrine and metabolic disorders (31 vs.
24%, p = 0.005), and eye diseases (19 vs. 10%, p < 0.001),
whereas the prevalence of stroke, chronic diseases of the re-
spiratory or digestive system, kidney diseases, and osteoporo-
sis was similar. Male cancer survivors more often reported
having blood disorders than non-cancer men (7 vs. 4%, p =
0.03). The analysis for the most prevalent cancers performed
separately in men and women demonstrated that the preva-
lence of osteoporosis (14.6 vs. 5.8%, p = 0.02), endocrine dis-
orders (31.7 vs. 17.6%, p = 0.02), and renal diseases (10.3 vs.
2.7%. p = 0.005) was higher in men with self-reported history
of prostate cancer than in men without any cancer history. The
distribution of comorbidities in women with breast cancer was
comparable to those without the cancer history.
History of cancer and association with impairments
In the multivariate logistic regressionmodel that controlled for
age, sex, marital status, education, and number of comorbid-
ities, cancer survivors were significantly more likely to report
falls (OR = 1.38; 95% CI:1.04–1.83), need for assistance
(OR = 1.37;95% CI: 1.04–1.81), and poor health status
(OR = 1.49; 95% CI:1.08–2.06), compared with subjects
without a history of cancer. Cancer history was not associated
with depression, cognitive impairment, or impairments in
performing IADLs (Table 2).
The status of cancer treatment (cured vs. ongoing therapy
and less than 5 years since the last treatment) had no significant
influence on the prevalence of depression (37.7 vs. 41.6%, p =
0.56), need for assistance (45.3 vs. 51%, p = 0.38), poor self-
reported health status (19.2 vs. 26.1%, p = 0.23), deficits in the
IADL score (50.4 vs. 54.9%, p = 0.49), or falls (32.4 vs.
21.6%, p = 0.06), the exception being the declared lower level
of social service support in cancer survivors who were cured of
cancer (2.2 vs. 10.2%, p = 0.008). In the multivariate logistic
regression model that controlled for time since diagnosis of
cancer, sex, age, education, and number of comorbidities, a
functional decline, i.e., decline in physical and cognitive func-
tioningwas associatedwith age; cancer survivors aged 80 years
or older had a 5.6-fold higher probability of limitations in the
IADL score, a fourfold higher probability of self-reported need
for assistance and 3.5-fold higher probability of cognitive dis-
order compared to cancer survivors aged 65–79 years old. In
addition, university education was associated with lower prob-
ability of functional decline, as cancer survivors with higher
education were less likely to report need for assistance (OR =
0.34; 95% CI: 0.14–0.85) or to have impairments in
performing IADLs (OR = 0.13; 95% CI: 0.05–0.35), cognitive
impairment (OR = 0.09; 95%CI: 0.02–0.42) and to report poor
health status (OR = 0.07; 95% CI: 0.01–0.56). Neither time
from cancer diagnosis nor the number of comorbidities was
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associated with the presence of impairments in cancer survi-
vors. The results are presented in Table 3.
Discussion
We found that cancer survivors over 65 years of age more
frequently experienced falls and presented poor health status
in comparison with those without cancer history. Moreover,
the octogenarians who survived cancer presented much higher
need for assistance due to limitations in functional status in
comparison to with younger subjects. Elderly cancer survivors
were also more likely to present multi-morbidity than patients
without a history of cancer.
Around one third of cancer survivors and less than a quarter of
respondentswithout a cancer history in our study reported having
experienced a fall within the previous year. The rate of falls in
community-dwelling older adults with cancer varies across stud-
ies and is estimated to be 20 to 33% [6]. After controlling for age,
sex, education, and comorbidities, a history of cancer was
Table 1 Characteristics of cancer survivors and adults without a history of cancer from the PolSenior Study
Self-reported cancer history No reported cancer history P value
Total
n = 286
Men
n = 158
Women
n = 128
Total
n = 4657
Men
n = 2394
Women
n = 2263
Age in years (SD) 79.4 (8.2) 80 (7.8) 78.6 (8.6) 79.3 (8.7) 79.4 (8.6) 79.2 (8.1) NS
Age < 0.001a,c
65–74 28.3 23.4 34.4 34.7 34.0 35.4
75–84 45.1 49.4 39.8 32.1 32.6 31.7
> 85 26.6 27.2 25.8 33.2 33.4 32.9
Male gender 55.2 – – 51.4 – – NS
MMSE< 24 pts 24.8 23.1 35.6 32.2 30 32.9 0.012a
IADL < 24 pts 49.8 49 50.8 52.2 50.2 54.2 NS
No. of chronic diseases
0 9.5 10.8 7.9 16.4 20 12.6 < 0.001a,b
0.022c1 22.1 25.3 18.1 22.8 23.9 21.6
2 17.9 22.8 11.8 22.8 23.3 22.4
3 50.5 41.1 62.2 38.0 32.9 43.4
Education < 0.001a
Elementary 45.1 39.5 52.0 59 50.8 68.7
High school 40.0 40.8 39.0 33 38.9 26.7
University 14.9 19.7 8.9 8 10.3 5.5
Marital status NS
Not married 49.4 32.9 69.6 50.6 29.9 72.6
Married 50.6 67.1 30.4 49.4 70.1 27.4
Living alone NS
Yes 20.5 14 28.5 21.5 14.5 28.8
No 79.5 86 71.5 78.5 85.4 71.2
Living in long-term facility NS
Yes 1.5 1.4 1.7 1.1 1.1 1.1
No 98.5 98.6 98.3 98.9 98.9 98.9
Social services 0.001a,c
Yes 6.2 6.6 5.7 2.8 1.9 3.6
No 93.8 93.4 94.3 97.2 98.5 96.4
Area of residence < 0.001a,b,c
Rural 28.0 29.8 25.8 40.6 39.2 41.9
Urban < 50,000 21.0 19.6 22.7 25.7 26.2 25.1
Urban > 50,000 51.0 50.6 51.6 33.8 34.5 33
Note values indicate percentages except for age in years
a Cancer survivors vs. non-cancer population
bWomen cancer survivors vs. non-cancer women
cMen cancer survivors vs. non-cancer men; NS not significant
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associated with the occurrence of falls in our study. Falls were
twice as frequent in elderly men with a history of prostate cancer
compared to men without a history of cancer. Exposure to an-
drogen deprivation therapy (ADT) in treating prostate cancer is
associatedwith a higher risk of falls than no such treatment [7]. A
study conducted by Mohile et al. also showed that elderly pa-
tients with cancer experience a higher prevalence of falls than
those without a history of cancer (26.4 vs. 21.9%) [8]. The side
effects of cancer therapy, e.g., peripheral neuropathy, fatigue, and
pain, are among the factors that could lead to functional impair-
ments and increase the incidence of falls in cancer survivors [9].
Apart from cancer and the long-term effects of treatment, the
higher prevalence of falls may also be a consequence of concom-
itant diseases, other medications, and aging.
Although elderly patients who fall frequently tend to have
deficits in functional ability, we did not observe an increased
incidence of deficits in performing the IADL tasks in the
group of cancer survivors studied. Other studies have also
reported maintained independence in cancer survivors.
Seventy-one percent of older patients with breast cancer with
a median follow-up of 5 years were found to be fully indepen-
dent in IADL tasks [10]. In contrast, Mohile et al. showed that
patients with a history of cancer had a significantly higher
prevalence of limitations in IADL tasks than the non-cancer
Table 2 Multivariate logistic model identifying factors associated with impairments among PolSenior study participants
Need for assistance IADL < 24 GDS ≥ 6 pts Falls MMSE< 24 pts Poor self-reported
health status
No cancer history – – – – – –
Cancer survivor 1.37 (1.04–1.81) 0.96 (0.72–1.28) 1.23 (0.93–1.63) 1.38 (1.04–1.83) 0.75 (0.54–1.05) 1.49 (1.08–2.06)
Sex
Male – – – – – –
Female 1.14 (0.98–1.32) 0.81 (0.69–0.94) 1.21 (1.04–1.41) 1.29 (1.09–1.51) 0.79 (0.67–0.93) 1.07 (0.88–1.30)
Age
65–79 years – – – – – –
80+ years 5.30 (1.60–6.11) 5.64 (1.90–6.50) 1.46 (1.26–1.68) 2.37 (1.03–2.77) 3.40 (2.93–3.95) 1.60 (1.34–1.92)
Education
Elementary – – – – – –
University 0.43 (0.33–0.57) 0.19 (0.14–0.24) 0.37 (0.28–0.49) 0.96 (0.73–1.26) 0.15 (0.10–0.21) 0.30 (0.38–0.76)
Marital status
Not married – – – – – –
Married 0.61 (0.53–0.71) 0.66 (0.57–0.77) 0.66 (0.57–0.78) 0.77 (0.65–0.91) 0.58 (0.49–0.68) 0.94 (0.77–1.15)
No. of chronic diseases
0 – – – – – –
1 1.24 (0.99–1.54) 1.18 (0.95–1.48) 1.16 (0.92–1.47) 1.28 (1.00–1.63) 1.14 (0.91–1.44) 1.45 (1.03–2.05)
2 1.46 (1.17–1.82) 1.06 (0.85–1.31) 1.56 (1.24–1.98) 1.41 (1.10–1.80) 0.93 (0.74–1.17) 1.78 (1.27–2.48)
3+ 2.87 (2.33–3.52) 1.77 (1.44–2.17) 2.32 (1.87–2.87) 1.72 (1.37–2.15) 1.02 (0.83–1.26) 3.20 (2.36–4.35)
Data are ORs (odds ratios) and 95% CI (confidence intervals). Dashes indicate reference categories. IADL instrumental activities of daily living, GDS
geriatric depression scale, MMSE mini mental state examination
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population (49.5 vs. 42.3%) [11]. Furthermore, individuals
with cancer reported more limitations in IADLs, with the most
common limitations being heavy housework (34%) and shop-
ping (17%) [12]. It is of note that around half of the population
in the PolSenior study had some impairment in performing
IADL tasks [13]. What is also noteworthy is that in elderly
cancer survivors, functional status was found to be associated
with the presence of comorbidities and level of education
rather than with the presence of cancer or time from diagnosis
[14]. In our study, functional decline in cancer survivors was
associated with age (5.6-fold higher odds of deficits in
performing IADL tasks among patients 80 years and older
compared with patients aged 65 to 79 years), but not with
the presence of comorbidities or time from diagnosis.
Cancer survivors who had university education were less like-
ly to present impairments in IADLs and cognitive dysfunc-
tion, to report need for assistance or poor health status than the
individuals with elementary education that might suggest that
higher education could be protective against detrimental influ-
ences of cancer and its treatment or it might contribute to the
better capacity to adapt to decreasing functional ability [15].
There were no significant differences in the prevalence of
impairments according to the status of cancer treatment.
Previous studies have shown an association of cancer history
with frailty, and falls are among the common features of frailty
[11]. The higher occurrence of falls in our population might be
a clinical manifestation of frailty in elderly cancer survivors.
Numerous studies have shown that cancer increases the risk
of developing depression in the elderly [16]. Data from the
Medicare Current Beneficiary Survey suggested that cancer
patients were more likely to experience depression compared
with non-cancer controls (OR = 1.15; 95% CI: 1.02–1.30) [8].
In contrast, the occurrence of depression in the PolSenior pop-
ulation of cancer survivors was associated with female sex, age,
and number of comorbidities, but not with the cancer diagnosis.
It has been suggested that elderly patients with cancer may
have a reduced risk of dementia [17]. These data were supported
in a 2015 meta-analysis of three studies analyzing the risk of
Alzheimer’s disease in patients with cancer [18]. Also, the results
of the Framingham Heart Study of 1278 participants aged
65 years or older without dementia at baseline who experienced
cancer indicated that they had a lower risk ofAlzheimer’s disease
(HR= 0.67; 95% CI: 0.47–0.97) [19]. Only a small number of
studies have reported that cancer survivors may experience long-
term cognitive deficits. In a study conducted by Heflin et al.,
14.5% of cancer survivors had cognitive dysfunction compared
with 8.7% of their cancer-free twins [20]. In our study, cancer
survivors presented lower prevalence of cognitive impairment in
univariate analysis, but it was not confirmed in multivariate lo-
gistic regression analysis, as having cognitive impairment was
Table 3 Multivariate logistic model identifying factors associated with impairments among cancer survivors
Need for assistance IADL < 24 GDS ≥ 6 pts Falls MMSE< 24 pts Poor self-reported
health status
Time from diagnosis
< 5 years – – – – – –
≥ 5 years 0.56 (0.29–1.09) 1.06 (0.54–2.12) 0.86 (0.44–1.69) 1.43 (0.70–2.91) 1.09 (0.45–2.64) 0.76 (0.35–1.68)
Sex
Male – – – – – –
Female 1.07 (0.56–2.04) 0.69 (0.35–1.37) 1.27 (0.66–2.45) 0.68 (0.34–1.34) 0.64 (0.28–1.51) 1.14 (0.51–2.55)
Age
65–79 years – – – – – –
80+ years 3.99 (2.13–7.45) 5.57 (2.85–10.90) 1.55 (0.83–2.86) 1.79 (0.95–3.39) 3.52 (1.61–7.68) 1.81 (0.85–3.89)
Education
Elementary – – – – – –
University 0.34 (0.14–0.85) 0.13 (0.05–0.35) 0.39 (0.15–1.00) 0.92 (0.36–2.31) 0.09 (0.02–0.42) 0.07 (0.01–0.56)
Marital status
Single – – – – – –
Married 1.26 (0.66–2.42) 1.15 (0.58–2.29) 1.58 (0.47–5.31) 0.67 (0.20–2.26) 0.40 (0.09–1.71) 0.88 (0.20–3.89)
No. of chronic diseases
0 – – – – – –
1 1.62 (0.50–5.29) 1.18 (0.33–4.21) 1.58 (0.47–5.31) 0.67 (0.20–2.26) 0.40 (0.09–1.71) 0.88 (0.20–3.89)
2 1.01 (0.30–3.48) 0.92 (0.25–3.34) 1.54 (0.44–5.34) 1.15 (0.34–3.82) 0.33 (0.07–1.59) 0.61 (0.13–2.89)
3+ 2.58 (0.86–7.73) 2.11 (0.66–6.81) 1.28 (0.42–3.93) 1.04 (0.36–3.06) 0.70 (0.20–2.46) 1.49 (0.41–5.44)
Data are ORs (odds ratios) and 95% CI (confidence intervals). Dashes indicate reference categories. IADL instrumental activities of daily living, GDS
geriatric depression scale, MMSE mini mental state examination
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associated with male sex, older age, elementary education, and
not being married, but not with cancer survivorship.
The reported incidence of comorbid conditions in cancer
survivors varies across studies. Results from a nationwide
study among all people living in Denmark indicated a higher
prevalence (40%) of a score ≥ 1 on the Charlson Comorbidity
Index (CCI) in older cancer survivors than in the non-cancer
population (16%). Cancer survivors had 59% higher odds of
having a CCI score ≥ 1 (95% CI: 1.57–1.60) after adjustment
for age and sex [21]. In a study conducted by Holmes et al. [4],
more elderly survivors reported having two or more chronic
conditions compared to controls (68 vs. 65%) and the age-
adjusted prevalence of cardiovascular diseases (excluding hy-
pertension) was higher in survivors (25 vs. 23%). Three out of
four elderly cancer survivors in the PolSenior study reported
having cardiovascular disorders. Cancer survivors treated with
cardiotoxic therapies are at increased risk of atherosclerosis
secondary to inflammation and endothelial dysfunction [22].
We have previously observed endothelial activation in young
adult survivors of childhood acute lymphoblastic leukemia ear-
ly after completing treatment [23]. On the other hand, other
studies found a similar prevalence of chronic conditions in
elderly cancer survivors and controls, except for a significantly
increased frequency of coronary artery disease and emphysema
in survivors [24]. In this study, the average number of comorbid
conditions in cancer survivors was 3, which was lower than in
participants without a history of malignancy. In our study, we
found an increased incidence of osteoporosis and endocrine
disorders among prostate cancer survivors. The high preva-
lence (53%) of osteoporosis has been previously documented
in men with prostate cancer on ADT [25]. Furthermore, ADT
increases the risk of diabetes in older men with prostate cancer,
particularly when other comorbidities are present [26]. In addi-
tion, ADT may be associated with an increased risk of demen-
tia [27]; nonetheless, we found no increased prevalence of cog-
nitive impairment in men with a self-reported prostate cancer
history and according to previously published data, the use of
ADT in the studied population was low [28]. Nevertheless, it
should be emphasized that due to the cross-sectional nature of
the data analyzed in the study, we cannot exclude the hypoth-
esis that the higher number of comorbidities was related to
superior health care and a more thorough diagnosis of concom-
itant diseases in cancer survivors.
Cancer survivorship among the older population has impli-
cations for their assessment of their general health status. Our
findings indicate that elderly cancer survivors more often report
poor health status than individuals without a history of cancer.
As mentioned above, the occurrence of falls may contribute to a
decline in perceived health status. In a cross-sectional study in
older cancer survivors who had a history of falls in the previous
year, falls were associated with lower scores for health-related
quality of life (HRQOL) and with a prospective decline in
HRQOL [29]. In the US National Health Interview Survey in
2010, almost twice as many cancer survivors (47% aged
65 years or older) as adults without a cancer history reported
poor mental health-related quality of life, and over a quarter of
cancer survivors reported poor physical health-related quality
of life. Having more than one comorbidity was found to be
associated with poor physical health-related quality of life in
both groups [30]. In the PolSenior study, having three or more
comorbidities was more strongly associated with poor self-
reported health status than cancer survivorship itself.
This study has some limitations. Data were self-reported,
which may have resulted in under- or over-reporting of informa-
tion and patients currently under treatment for cancer might have
been underrepresented in the study. Unfortunately, we did not
have access to all records of the type and status of cancer treat-
ment. The data on type of cancer, age at diagnosis, and status of
cancer treatment could be verified with hospital discharge reports
when provided by the patient. Furthermore, cognitive impair-
ment was assessed using screening test (MMSE), which may
be influenced by age, education, motor, and visual impairments.
In conclusion, cancer survivors over the age of 65 years
experience a higher prevalence of falls, are more likely to
report poor health status, and have a higher number of chronic
conditions than the non-cancer elderly population, but they
maintain independence in IADLs. Advanced age and lower
education, but not time from cancer diagnosis, are associated
with the occurrence of impairments in older cancer survivors.
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